Capricor Therapeutics financial statements

캐프리코 테라퓨틱스NASDAQ:CAPR · Nasdaq · Healthcare · sector #17
$7.75-0.39%
2026-10-06 close

Capricor Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $22M. 2024 operating profit was −$43M.

Reported results

Capricor Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q